Vanda Pharma jumps as US FDA approves new antipsychotic pill
ReutersFeb 23, 2026 11:31 AM
Shares of Vanda Pharmaceuticals VNDA.O rise 37% to $7.91 premarket
On late Friday, the U.S. FDA approved VNDA's drug for the treatment of two serious mental health conditions
The drug, Bysanti, is an antipsychotic pill aimed at treating schizophrenia and acute bipolar I disorder
Market exclusivity for Bysanti expected to extend to 2044, "providing a robust foundation for long-term innovation and patient benefit," said H.C. Wainwright analyst
Vanda's extremely modest enterprise value does not reflect the commercial potential of the company's approved product portfolio, let alone its extensive pipeline - H.C. Wainwright
In 2025, VNDA rose 84.1%
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
International Copper Prices Rise for 7 Straight Months; Will Bull Market Continue in 2026?
TradingKey - As the "king of industrial metals," every fluctuation in international copper prices impacts the nerves of global investors. In early 2026, international copper prices continued to rise, extending the upward trend from 2025 and reaching a new high above $14,500, marking seven consecutive months of gains. Meanwhile, London Metal Exchange (LME) copper prices have climbed from $7,800 per tonne in July 2025 to over $9,000 per tonne today.TradingKey
6 hours ago
How Bitcoin Miners Are Scaling Revenue Through AI Data Center Integration
Discover how Bitcoin miners like Core Scientific and IREN are scaling revenue by pivoting to AI data centers. Explore 2026 hashprice trends, ASIC-to-GPU retrofitting, and the "hashrate-to-HPC" revolution.TradingKey
Sun, Feb 22
Stock Market Crash 2026: What Fed Signals and Economic Data Mean for Investors
TradingKey - The possibility of a stock market crash occurring in 2026 is becoming increasingly likely as investor sentiment continues to decline.TradingKey
Thu, Feb 19
New Fed Chair Warsh Takes Office: Major Shift in Monetary Policy? US Dollar Short-Term Rebound, 2026 Investment Strategy Analysis
TradingKey - At the start of 2026, global financial markets witnessed a major leadership change as U.S. President Trump officially nominated Kevin Warsh as the next Federal Reserve Chair. Pending Senate confirmation, he will succeed Jerome Powell this May to lead the world’s most influential central bank.TradingKey
Thu, Feb 19
